Report Library
All Reports
Key Potential Drug Launches in 2020
May 28, 2019
As a supplement to our well-known quarterly Outlook report, Biomedtracker is pleased to present a longer-term look at some key late-
stage drugs projected to hit the market in 2020. These drugs represent new drug classes, major changes to standards of care, and/or large
market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.
To view the full report, download the PDF at the top of this page. Additionally, an Excel list of relevant upcoming catalysts for these drugs can be downloaded under the support material.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the Biomedtracker Research Standards.
To view the full report, download the PDF at the top of this page. Additionally, an Excel list of relevant upcoming catalysts for these drugs can be downloaded under the support material.
Like our report? Have any questions or feedback? Please let us know at askanalyst@sagientresearch.com.
For our disclosures, please read the Biomedtracker Research Standards.
| Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine Hematology Infectious Disease Metabolic Neurology Obstetrics/Gynecology Oncology Ophthalmology Psychiatry Renal Respiratory |
Additional Resources:
- Datamonitor Healthcare I&I: Acne Market Spotlight
- 2019 Biomedtracker / Datamonitor Healthcare Post-AAN Report
- 2019 Biomedtracker / Datamonitor Healthcare Pre-ASCO Podcast
- Datamonitor Healthcare Oncology: Basal Cell Carcinoma Market Spotlight
- 2019 Biomedtracker / Datamonitor Healthcare ASCO Planner
- 2019 Biomedtracker / Datamonitor Healthcare Pre-ASCO Report